Skip to the page

Data / Form D filings / Variation Biotechnologies (US), Inc.

Variation Biotechnologies (US), Inc.: Form D filings

Variation Biotechnologies (US), Inc., a biotechnology company in Cambridge, MA, filed 10 Form D notices with the SEC between 2011 and 2014. The latest, on March 25, 2014, reports $1.5 million sold of a $1.5 million offering to 8 investors.

Find out what Variation Biotechnologies (US), Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
222 3RD STREET, SUITE 2241, Cambridge, MA, 02142
Phone
(617) 830-3031
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1525594

The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 25, 2014New notice$1,500,000$1,500,000$08Mar 10, 2014sec.gov
Dec 24, 2013New notice$1,375,000$1,375,000$02Sep 30, 2013sec.gov
Sep 10, 2013New notice$250,000$250,000$02Aug 26, 2013sec.gov
Jun 20, 2013New notice$750,000$750,000$02Jun 10, 2013sec.gov
Mar 8, 2013New notice$751,061$751,061$04Feb 22, 2013sec.gov
Nov 9, 2012New notice$1,200,000$1,200,000$04Oct 24, 2012sec.gov
Jun 29, 2012New notice$1,200,000$1,200,000$04Jun 20, 2012sec.gov
Feb 10, 2012New notice$2,200,000$2,200,000$04Dec 14, 2011sec.gov
Jul 15, 2011New notice$3,500,000$3,500,000$04Jun 3, 2011sec.gov
Jul 15, 2011New notice$4,331,932$4,331,932$04Nov 17, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David E. AndersonExecutive Officer
Stephen GillisDirector
Steve VignauDirector
Michael SteinmetzDirector
Egidio NascimentoExecutive Officer
Jeff BaxterExecutive Officer, Director
Kevin ForrestDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Mar 24, 2014 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Variation Biotechnologies (US), Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.